what is tirzepatide derived from Insights into the Mechanism of Action of Tirzepatide: A Narrative Review Tirzepatide (TZP) is a 39-amino

Morfeld M, Petersen C, Krger-Bdeker A, Von Mackensen S, Bullinger M

Zepbound (Tirzepatide) is not for insulin-dependent diabetics (type 1 diabetes)

Patients with insulin resistance, prediabetes, or type 2 diabetes often benefit most from GLP-1 or dual agonist therapies such as Wegovy, Ozempic, Mounjaro, or ZepBound

52 Tirzepatide also improved sleep-associated patient-reported outcomes

People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications